---
title: "SXTP Q1'26 Earnings: EPS estimate is (0.76) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286247156.md"
description: "SXTP (60 Degrees Pharmaceuticals, Inc.) will announce its Q1'26 earnings on May 14 at 8:00 AM ET. The revenue estimate is $435,000, with an anticipated EPS of $(0.76). Previous quarters showed significant revenue surprises and varying EPS results. For Q1'25, reported revenue was $163.60K, and for Q4'25, it was $300K. The EPS has shown a downward trend, with reported values ranging from $(6.24) to $(1.91) in the last four quarters."
datetime: "2026-05-13T11:00:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286247156.md)
  - [en](https://longbridge.com/en/news/286247156.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286247156.md)
---

# SXTP Q1'26 Earnings: EPS estimate is (0.76) USD

SXTP (60 Degrees Pharmaceuticals, Inc.) is set to announce its Q1'26 results on May 14, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 435.00 thousand USD with EPS (earnings per share) anticipated at (0.76) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

163.60 K

305.00 K

500.00 K

300.00 K

—

**Revenue Estimate**

300.00 K

320.00 K

200.00 K

320.00 K

435.00 K

**Revenue Surprise**

\-45.47%

\-4.69%

+150.00%

\-6.25%

**EPS Reported**

(6.24)

(4.82)

(2.67)

(1.91)

**EPS Estimate**

(5.26)

(4.96)

(1.84)

(1.47)

(0.76)

**EPS Surprise**

\-18.63%

+2.82%

\-45.11%

\-29.93%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [SXTP.US](https://longbridge.com/en/quote/SXTP.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SXTPW.US](https://longbridge.com/en/quote/SXTPW.US.md)

## Related News & Research

- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says](https://longbridge.com/en/news/286290495.md)
- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)